Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Atom Bioscience & Pharmaceutical
company
About
Atom Bioscience is a clinical-stage biotechnology company.
- 1 - 10
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $45M
- Industries
- Biotechnology,Health Care
- Founded date
- Jan 1, 2012
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$48.07M
Atom Bioscience & Pharmaceutical has raised a total of
$48.07M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2022 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2022 | Series C | $45M | 1 | — | — | Detail |
| Jun 21, 2018 | Series A | $3.07M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Atom Bioscience & Pharmaceutical is funded by 2 investors.
Unifortune
and Ch-gemstone capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Unifortune
|
— | Series C |
Ch-gemstone capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
